1492 Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

1492 Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-790,863	Closed	-$3.32M	–	129
2020 Q4	$3.32M	Sell	790,863 -13,627	-2%	-$52.5K	1.91%	21
2020 Q3	$3M	Buy	804,490 +4,460	+0.6%	+$19K	2.25%	12
2020 Q2	$3.49M	Sell	800,030 -13,158	-2%	-$59.1K	2.99%	8
2020 Q1	$3.08M	Sell	813,188 -12,494	-2%	-$61.4K	3.69%	5
2019 Q4	$5.22M	Buy	825,682 +47,199	+6%	+$277K	4.61%	3
2019 Q3	$3.28M	Sell	778,483 -7,520	-1%	-$32.1K	3.2%	5
2019 Q2	$3.65M	Sell	786,003 -13,358	-2%	-$62.2K	3.42%	5
2019 Q1	$4.24M	Sell	799,361 -82,427	-9%	-$376K	3.59%	5
2018 Q4	$3.26M	Buy	881,788 +561,265	+175%	+$1.97M	2.93%	8
2018 Q3	$897K	Buy	+320,523	New	+$900K	0.58%	52
2016 Q1	–	Sell	-538,538	Closed	-$2.58M	–	136
2015 Q4	$2.58M	Buy	538,538 +41,069	+8%	+$233K	1.88%	18
2015 Q3	$2.77M	Buy	497,469 +165,140	+50%	+$1.22M	1.97%	13
2015 Q2	$2.65M	Buy	332,329 +262,860	+378%	+$2.26M	1.67%	23
2015 Q1	$729K	Buy	69,469 +12,746	+22%	+$174K	0.42%	63
2014 Q4	$682K	Buy	+56,723	New	+$862K	0.43%	69

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

1492 Capital Management's BDSI Position: Q1 2021 in Review

1492 Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 790,863 shares — an estimated $3.32M sold.

1492 Capital Management first reported a position in BDSI in Q4 2014 and held it in 15 quarters. The position peaked at $5.22M in Q4 2019. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

1492 Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
1492 Capital Management sold 790,863 BioDelivery Sciences International, Inc. shares in Q1 2021, an estimated $3.32M.
1492 Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 15 quarters.
1492 Capital Management's BioDelivery Sciences International, Inc. position peaked at $5.22M in Q4 2019.
151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on 1492 Capital Management's 13F filing for Q1 2021, filed 12 May 2021.